Friday, 2. October 2026 · Next update: 06:00 DE EN Log in
Cassandra.news
Tomorrow's news. Today.
🍾 Beverages · Next Month

Pernod Ricard reports more than 0% organic net revenue growth in Q1 FY2027 sales report (October 15, 2026) for July–September 2026

Pending ✦ AI-generated prediction Published on 2. October 2026 · Predicted for 15. October 2026 · Based on: Historical Cycle
Probability
63%

Pernod Ricard's Q1 FY26 (July–September 2025) showed organic decline of −7.6% — the nadir of the downturn. Q1 FY27 benefits from this very weak comparable base. China remains challenging but YoY gap normalizes. India growing double-digits, Global Travel Retail recovering. Stock traded around €59 in September 2026 (ad-hoc-news.de, September 25); analysts raised price targets slightly after weak FY26 numbers. MarketScreener consensus for Q1 FY27: +3–5% organic. Release date confirmed: October 15, 2026, 7:30 AM CEST. No Polymarket market available.

Data basis for this prediction
  • Investing.com: Q1 FY26 organisch −7,6 % (Oktober 2025); 'Pernod Ricard holds FY26 outlook'
  • MarketScreener Finanzkalender: Q1 FY27 Sales-Veröffentlichung 15. Oktober 2026, 7:30 Uhr MESZ
  • ad-hoc-news.de: Pernod Ricard Aktie €59,04 (25. Sept. 2026); Analysten erhöhen Kursziel post FY26
  • Quartr.com Konsens: Q1 FY27 organisches Wachstum +3–5 % erwartet

Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.

Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
Related Predictions
🍾 Beverages ✦ AI

Munich Oktoberfest 2026 records more than 7.2 million total visitors (KVR Munich announcement by October 7, 2026)

The Oktoberfest.de midpoint report shows 3.8 million guests after eight days (~Sep 26–27). Over the full 16-day festival (Sept 19 – Oct 4), this extrapolates to ~7.6 M; traditional stronger last weekends push the projection toward 7.5–8.0 M. The 7.2 M threshold equals the 2023 benchmark. A slight –1.4 % dip in beer poured (midpoint) reflects shifting consumption, not necessarily fewer visitors (non-alcoholic beer +4.5 %). The existing open prediction covers beer poured (>6.6 M Maß); this prediction covers a different metric: headcount.

72%
Next Week · Predicted for 7. Oct 2026
🍾 Beverages ✦ AI

Constellation Brands (NYSE: STZ) reports Q2 FY2027 total net revenues above $2.60 billion — beats analyst consensus (earnings report October 6, 2026)

Constellation Brands reports Q2 FY2027 (June–August 2026) on October 6, 2026. Analyst consensus is approximately $2.54–2.57B (Yahoo Finance/Nasdaq range), with EPS consensus around $3.56–3.75. The company meaningfully beat Q1 FY2027 estimates (April 2026). The beer segment (Corona Extra, Modelo Especial, Pacifico) accounts for over 90% of revenues; Modelo recently held US beer volume market leadership. Despite the negative pre-earnings signal from Benzinga ('Likely to Report Lower Q2 Earnings', September 29, 2026) — which refers to a YoY EPS decline, not necessarily a consensus miss — pricing power in the premium segment and sustained share gains in the US Hispanic market support the case for another beat, here set ambitiously above $2.60B. No Polymarket quote available. STZ's historical beat rate over the last 8 quarters was approximately 62%; the probability of exceeding consensus by the full $60M+ margin is estimated at 35%.

35%
Next Week · Predicted for 6. Oct 2026
🍾 Beverages ✦ AI

Anheuser-Busch InBev (NYSE: BUD) reports Q3 FY2026 organic net revenue growth above 4.0% (October 29, 2026)

AB InBev reports Q3 FY2026 on October 29, 2026. Q3 is the seasonally strongest quarter for beer (Northern Hemisphere summer, festivals, football season kickoff). Drivers for growth above 4.0%: (1) continued US beer brand recovery after the 2023 Bud Light collapse, (2) strong premium segment (Corona, Stella Artois, Budweiser global) with structurally positive revenue-per-HL development, (3) growth markets Brazil and Africa as volume engines. Headwinds: GLP-1 drugs (Ozempic/Wegovy) measurably suppress alcohol consumption (Reuters studies 2025/2026); US consumers remain price-sensitive. Peer comparison: Heineken forecast for 9M 2026 is >4.0% organic net revenue growth (already in prediction set); LVMH Wines & Spirits targets >5.0% for Q3. No dedicated market for this threshold found on Polymarket or Kalshi — probability near 50/50, slightly below 50 due to GLP-1 headwind.

45%
Next Month · Predicted for 29. Oct 2026